However, in breast cancer cells with mutant PIK3CA, a well-known downstream target of EGFR signaling, knockdown of flotillin-1 causes an upregulation of EGFR and hyperactivation of MAPK signaling. The gene discussed is FLOT1; the disease is breast cancer.